Literature DB >> 34112760

A variant in IL6ST with a selective IL-11 signaling defect in human and mouse.

Tobias Schwerd1,2, Freia Krause3, Stephen R F Twigg4, Andrew O M Wilkie4,5, Dirk Schmidt-Arras3, Holm H Uhlig6,7,8, Dominik Aschenbrenner1, Yin-Huai Chen1, Uwe Borgmeyer9, Miryam Müller3,10, Santiago Manrique11, Neele Schumacher3, Steven A Wall5, Jonathan Jung1,12, Timo Damm13, Claus-Christian Glüer13, Jürgen Scheller14, Stefan Rose-John3, E Yvonne Jones11, Arian Laurence1.   

Abstract

The GP130 cytokine receptor subunit encoded by IL6ST is the shared receptor for ten cytokines of the IL-6 family. We describe a homozygous non-synonymous variant in IL6ST (p.R281Q) in a patient with craniosynostosis and retained deciduous teeth. We characterize the impact of the variant on cytokine signaling in vitro using transfected cell lines as well as primary patient-derived cells and support these findings using a mouse model with the corresponding genome-edited variant Il6st p.R279Q. We show that human GP130 p.R281Q is associated with selective loss of IL-11 signaling without affecting IL-6, IL-27, OSM, LIF, CT1, CLC, and CNTF signaling. In mice Il6st p.R279Q lowers litter size and causes facial synostosis and teeth abnormalities. The effect on IL-11 signaling caused by the GP130 variant shows incomplete penetrance but phenocopies aspects of IL11RA deficiency in humans and mice. Our data show that a genetic variant in a pleiotropic cytokine receptor can have remarkably selective defects.

Entities:  

Year:  2020        PMID: 34112760     DOI: 10.1038/s41413-020-0098-z

Source DB:  PubMed          Journal:  Bone Res        ISSN: 2095-4700            Impact factor:   13.567


  48 in total

1.  STAT3 mutations in the hyper-IgE syndrome.

Authors:  Steven M Holland; Frank R DeLeo; Houda Z Elloumi; Amy P Hsu; Gulbu Uzel; Nina Brodsky; Alexandra F Freeman; Andrew Demidowich; Joie Davis; Maria L Turner; Victoria L Anderson; Dirk N Darnell; Pamela A Welch; Douglas B Kuhns; David M Frucht; Harry L Malech; John I Gallin; Scott D Kobayashi; Adeline R Whitney; Jovanka M Voyich; James M Musser; Cristina Woellner; Alejandro A Schäffer; Jennifer M Puck; Bodo Grimbacher
Journal:  N Engl J Med       Date:  2007-09-19       Impact factor: 91.245

2.  Osteoclasts are present in gp130-deficient mice.

Authors:  K Kawasaki; Y H Gao; S Yokose; Y Kaji; T Nakamura; T Suda; K Yoshida; T Taga; T Kishimoto; H Kataoka; T Yuasa; H Norimatsu; A Yamaguchi
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

3.  Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth.

Authors:  Pekka Nieminen; Neil V Morgan; Aimée L Fenwick; Satu Parmanen; Lotta Veistinen; Marja L Mikkola; Peter J van der Spek; Andrew Giraud; Louise Judd; Sirpa Arte; Louise A Brueton; Steven A Wall; Irene M J Mathijssen; Eamonn R Maher; Andrew O M Wilkie; Sven Kreiborg; Irma Thesleff
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

Review 4.  Hyper-IgE syndromes.

Authors:  Bodo Grimbacher; Steven M Holland; Jennifer M Puck
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

5.  Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.

Authors:  B Grimbacher; S M Holland; J I Gallin; F Greenberg; S C Hill; H L Malech; J A Miller; A C O'Connell; J M Puck
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

6.  A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation.

Authors:  Shousaku Itoh; Nobuyuki Udagawa; Naoyuki Takahashi; Fumio Yoshitake; Hiroko Narita; Shigeyuki Ebisu; Katsuhiko Ishihara
Journal:  Bone       Date:  2006-05-06       Impact factor: 4.398

Review 7.  Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines.

Authors:  Masaaki Murakami; Daisuke Kamimura; Toshio Hirano
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

8.  Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro.

Authors:  Hong-In Shin; Paola Divieti; Natalie A Sims; Tatsuya Kobayashi; Dengshun Miao; Andrew C Karaplis; Roland Baron; Richard Bringhurst; Henry M Kronenberg
Journal:  Endocrinology       Date:  2003-11-14       Impact factor: 4.736

9.  A boy with recurrent infections, impaired PMN-chemotaxis, increased IgE concentrations and cranial synostosis--a variant of the hyper-IgE syndrome?

Authors:  M Gahr; W Müller; B Allgeier; C P Speer
Journal:  Helv Paediatr Acta       Date:  1987-10

10.  Craniosynostosis in hyper-IgE-syndrome.

Authors:  P H Höger; E Boltshauser; W H Hitzig
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

View more
  1 in total

Review 1.  Insights and future directions of potential genetic therapy for Apert syndrome: A systematic review.

Authors:  Nisreen Mohammed Al-Namnam; Soher Nagi Jayash; Firdaus Hariri; Zainal Ariff Abdul Rahman; Mohammed Abdullah Alshawsh
Journal:  Gene Ther       Date:  2021-02-22       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.